- Home
- RSKD vs FTRE Comparison
RSKD vs FTRE Comparison
Compare RSKD & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSKD
- FTRE
- Stock Information
- Founded
- RSKD 2012
- FTRE 1996
- Country
- RSKD United States
- FTRE United States
- Employees
- RSKD N/A
- FTRE N/A
- Industry
- RSKD EDP Services
- FTRE Medical Specialities
- Sector
- RSKD Technology
- FTRE Health Care
- Exchange
- RSKD Nasdaq
- FTRE Nasdaq
- Market Cap
- RSKD 851.6M
- FTRE 701.9M
- IPO Year
- RSKD 2021
- FTRE N/A
- Fundamental
- Price
- RSKD $4.74
- FTRE $10.65
- Analyst Decision
- RSKD Hold
- FTRE Hold
- Analyst Count
- RSKD 7
- FTRE 9
- Target Price
- RSKD $5.79
- FTRE $12.06
- AVG Volume (30 Days)
- RSKD 713.1K
- FTRE 1.9M
- Earning Date
- RSKD 11-12-2025
- FTRE 11-07-2025
- Dividend Yield
- RSKD N/A
- FTRE N/A
- EPS Growth
- RSKD N/A
- FTRE N/A
- EPS
- RSKD N/A
- FTRE N/A
- Revenue
- RSKD $335,825,000.00
- FTRE $2,733,500,000.00
- Revenue This Year
- RSKD $6.27
- FTRE N/A
- Revenue Next Year
- RSKD $9.63
- FTRE N/A
- P/E Ratio
- RSKD N/A
- FTRE N/A
- Revenue Growth
- RSKD 7.96
- FTRE N/A
- 52 Week Low
- RSKD $3.94
- FTRE $3.97
- 52 Week High
- RSKD $6.00
- FTRE $25.28
- Technical
- Relative Strength Index (RSI)
- RSKD 50.96
- FTRE 65.70
- Support Level
- RSKD $4.43
- FTRE $9.82
- Resistance Level
- RSKD $4.80
- FTRE $10.87
- Average True Range (ATR)
- RSKD 0.16
- FTRE 0.66
- MACD
- RSKD 0.02
- FTRE -0.10
- Stochastic Oscillator
- RSKD 77.22
- FTRE 48.05
About RSKD Riskified Ltd.
Riskified Ltd has built a next-generation eCommerce risk management platform that allows online merchants to create trusted relationships with their consumers. It generates revenue by granting merchants access to its eCommerce risk management platform and reviewing and approving eCommerce transactions for legitimacy. Its merchants include some of the ecommerce brands including Wayfair, Lastminute.com, SHEIN, and Macy's. Its merchants operate in a variety of verticals, including Payments, Money Transfer & Crypto, Tickets & Travel, Electronics, Home, Fashion & Luxury Goods, General Retail and Food. The company derived maximum revenue from Israel.
About FTRE Fortrea Holdings Inc.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.